154 related articles for article (PubMed ID: 23252972)
1. A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis.
Majima Y; Yagi H; Tateishi C; Groth S; Schmidt E; Zillikens D; Koga H; Hashimoto T; Tokura Y
Br J Dermatol; 2013 Jun; 168(6):1367-9. PubMed ID: 23252972
[No Abstract] [Full Text] [Related]
2. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
[No Abstract] [Full Text] [Related]
3. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
4. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
[No Abstract] [Full Text] [Related]
5. Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Kayaba H; Sawamura D
J Dermatol; 2020 Jan; 47(1):e25-e26. PubMed ID: 31646656
[No Abstract] [Full Text] [Related]
6. Anti-laminin-gamma 1 Pemphigoid with Generalized Pustular Psoriasis and Psoriasis Vulgaris.
Fujimura Y; Natsuga K; Hamade Y; Nomura Y; Kaku Y; Muramatsu R; Shimizu H
Acta Derm Venereol; 2016 Jan; 96(1):120-1. PubMed ID: 26074471
[No Abstract] [Full Text] [Related]
7. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
8. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
[No Abstract] [Full Text] [Related]
9. Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis.
Solimani F; Pollmann R; Ishii N; Eming R; Hashimoto T; Schmidt T; Hertl M
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):735-741. PubMed ID: 29972879
[TBL] [Abstract][Full Text] [Related]
10. Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.
Ashida H; Hamada T; Hosokawa Y; Hashimoto T; Nishie W; Ishii N; Nakama T; Kanno T; Ikeda M
Acta Derm Venereol; 2019 Nov; 99(12):1172-1173. PubMed ID: 31449311
[No Abstract] [Full Text] [Related]
11. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis.
Kitayama S; Makino T; Kataoka K; Mori S; Takemoto K; Furukawa F; Torai R; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
J Dtsch Dermatol Ges; 2024 May; 22(5):713-715. PubMed ID: 38593343
[No Abstract] [Full Text] [Related]
13. Bullous pemphigoid without detection of autoantibodies in a patient with psoriasis under ustekinumab.
Querol-Cisneros E; Moreno-Artero E; Rodríguez-Garijo N; Tomás-Velázquez A; Querol I; Ishii N; Hashimoto T; España A
J Dtsch Dermatol Ges; 2021 Feb; 19(2):265-267. PubMed ID: 32743906
[No Abstract] [Full Text] [Related]
14. Anti-laminin γ1 pemphigoid associated with pustular psoriasis.
Igarashi M; Tsunemi Y; Koga H; Hashimoto T; Tateishi C; Tsuruta D; Ishii M; Kawashima M
Eur J Dermatol; 2014; 24(5):629-30. PubMed ID: 25075951
[No Abstract] [Full Text] [Related]
15. A case of refractory antilaminin γ1 pemphigoid successfully treated with dexamethasone and mycophenolate mofetil.
Zhiliang L; Xiaodong Z; Peiying J; Suying F; Baoxi W
Int J Dermatol; 2015; 54(5):e194-6. PubMed ID: 25773159
[No Abstract] [Full Text] [Related]
16. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
17. Anti-laminin γ1 pemphigoid accompanied by autoantibodies to laminin α3 and γ2 subunits of laminin-332.
Kamata M; Fujita H; Hamanaka T; Takahashi K; Koga H; Hashimoto T; Sato S
JAMA Dermatol; 2013 Dec; 149(12):1437-9. PubMed ID: 24154702
[No Abstract] [Full Text] [Related]
18. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
[No Abstract] [Full Text] [Related]
19. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
[TBL] [Abstract][Full Text] [Related]
20. A case of concurrent antilaminin γ1 pemphigoid and antilaminin-332-type mucous membrane pemphigoid.
Li X; Qian H; Ishii N; Yamaya M; Fukuda H; Mukai H; Hirako Y; Hashimoto T
Br J Dermatol; 2014 Nov; 171(5):1257-9. PubMed ID: 25262782
[No Abstract] [Full Text] [Related]
[Next] [New Search]